MYCN and neuroblastoma: In conclusion, a complex interplay of genetic changes, such as MYCN amplification, segmental chromosomal modifications, gene expression profiles, ALK mutations, and other genomic variants, contributes to the complex pathogenesis of neuroblastoma.